From Node to Pathway Blockade: Lessons Learned From Targeting Mammalian Target of RapamycinHIDALGO, Manuel.Journal of clinical oncology. 2012, Vol 30, Num 1, pp 85-87, issn 0732-183X, 3 p.Article

Targeted TherapiesHIDALGO, Manuel.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, issn 0889-8588, 286 p.Serial Issue

Development of matrix metalloproteinase inhibitors in cancer therapyPURCELL, W. Thomas; RUDEK, Michelle A; HIDALGO, Manuel et al.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, issn 0889-8588, viii, 1189-1227 [40 p.]Article

Developing inhibitors of the epidermal growth factor receptor for cancer treatmentGRÜNWALD, Viktor; HIDALGO, Manuel.Journal of the National Cancer Institute. 2003, Vol 95, Num 12, pp 851-867, issn 0027-8874, 17 p.Article

Clinical development of mammalian target of rapamycin inhibitorsDANCEY, Janet E.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, issn 0889-8588, vi, 1101-1114 [15 p.]Article

Multitargeted therapy : Can promiscuity be praised in an era of political correctness?JIMENO, Antonio; HIDALGO, Manuel.Critical reviews in oncology/hematology. 2006, Vol 59, Num 2, pp 150-158, issn 1040-8428, 9 p.Article

Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the PancreasHIDALGO, Manuel; VON HOFF, Daniel D.Clinical cancer research (Print). 2012, Vol 18, Num 16, pp 4249-4256, issn 1078-0432, 8 p.Article

Development of the epidermal growth factor receptor inhibitor OSI-774GRÜNWALD, Viktor; HIDALGO, Manuel.Seminars in oncology. 2003, Vol 30, Num 3, pp 23-31, issn 0093-7754, 9 p., SUP6Article

Epoxy-Based Networks Combining Chemical and Supramolecular Hydrogen-Bonding CrosslinksMONTARNAL, Damien; TOURNILHAC, François; HIDALGO, Manuel et al.Journal of polymer science. Part A. Polymer chemistry. 2010, Vol 48, Num 5, pp 1133-1141, issn 0887-624X, 9 p.Article

Epithelial growth factor receptor interacting agentsBASELGA, Jose; ALBANELL, Joan.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, issn 0889-8588, v, 1041-1063 [24 p.]Article

Inhibitors of the ras oncogene as therapeutic targetsGHOBRIAL, Irene M; ADJEI, Alex A.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, pp v-vi, issn 0889-8588, 26 p.Article

Targeting intracellular signal transduction A new paradigm for a brave new world of molecularly targeted therapeuticsBEERAM, Muralidhar; PATNAIK, Amita.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, issn 0889-8588, vi, 1089-1100 [13 p.]Article

Heat shock protein and proteasome targeting agentsTAKIMOTO, Chris H; DIGGIKAR, Shrinivas.Hematology/oncology clinics of North America. 2002, Vol 16, Num 5, issn 0889-8588, ix, 1269-1285 [18 p.]Article

The rapamycin-sensitive signal transduction pathway as a target for cancer therapyHIDALGO, Manuel; ROWINSKY, Eric K.Oncogene (Basingstoke). 2000, Vol 19, Num 56, pp 6680-6686, issn 0950-9232Article

Influence of environmental parameters on the life-history and population dynamics of cuttlefish Sepia officinalis in the western MediterraneanKELLER, Stefanie; VALLS, Maria; HIDALGO, Manuel et al.Estuarine, coastal and shelf science (Print). 2014, Vol 145, pp 31-40, issn 0272-7714, 10 p.Article

Pharmacokinetics and pharmacodynamics: Maximizing the clinical potential of erlotinib (Tarceva)HIDALGO, Manuel; BLOEDOW, Duane.Seminars in oncology. 2003, Vol 30, Num 3, pp 25-33, issn 0093-7754, 9 p., SUP7Article

Synthèse et caractérisation physicochimique et thermomécanique des matériaux filmogènes issus de latex à base styrène-acrylate de butyle fonctionnalisés = Synthesis and physicochemical and thermomechanical characterization of film-forming materials from functionalized styrene/butyl acrylate-based latexesHidalgo, Manuel; Guillot, Jean; Cavaille, Jean-Yves et al.1992, 249 p.Thesis

An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivityRUPPEN-CANAS, Isabel; LOPEZ-CASAS, Pedro P; GARCIA, Fernando et al.Proteomics (Weinheim. Print). 2012, Vol 12, Num 9, pp 1319-1327, issn 1615-9853, 9 p.Article

Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene lengthLIN, Ming-Tseh; TSENG, Li-Hui; KAMIYAMA, Hirohiko et al.BioTechniques. 2010, Vol 48, Num 3, issn 0736-6205, 211-218 [6 p.]Article

Laboratory Evaluation of Kinetic Hydrate Inhibitors: A Procedure for Enhancing the Repeatability of Test ResultsDUCHATEAU, Christophe; PEYTAVY, Jean-Louis; GLENAT, Philippe et al.Energy & fuels. 2009, Vol 23, Num 1, pp 962-966, issn 0887-0624, 5 p.Article

Population effects and changes in life history traits in relation to phase transitions induced by long-term fishery harvesting: European hake (Merluccius merluccius) off the Balearic IslandsHIDALGO, Manuel; MASSUTI, Enric; GUIJARRO, Beatriz et al.Canadian journal of fisheries and aquatic sciences (Print). 2009, Vol 66, Num 8, pp 1355-1370, issn 0706-652X, 16 p.Article

Structural characterization of a poly(methacrylic acid)-poly(methyl methacrylate) copolymer by nuclear magnetic resonance and mass spectrometryGIORDANENGO, Rémi; VIEL, Stéphane; HIDALGO, Manuel et al.Analytica chimica acta. 2009, Vol 654, Num 1, pp 49-58, issn 0003-2670, 10 p.Conference Paper

A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assayMING ZHAO; RUDEK, Michelle A; PING HE et al.Journal of chromatography. B. 2007, Vol 846, Num 1-2, pp 1-7, issn 1570-0232, 7 p.Article

Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumorsERLICHMAN, Charles; HIDALGO, Manuel; BONI, Joseph P et al.Journal of clinical oncology. 2006, Vol 24, Num 15, pp 2252-2260, issn 0732-183X, 9 p.Article

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neckSOULIERES, Denis; SENZER, Neil N; VOKES, Everett E et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 77-85, issn 0732-183X, 9 p.Article